Monday, November 2, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1orforglipronsemaglutidewegovyoral glp-1

Fierce Pharma tracker shows minor shifts for Foundayo and Wegovy pill

The running tally of oral GLP-1 uptake registered only small week-over-week movement across the two launched products.

MH
By Maren Holt · Senior Reporter, GLP-1
Oct 16 03:00 ETSource: Fierce Pharma

The wire

  1. 01Fierce Pharma's oral GLP-1 tracker reported minor fluctuations in the latest update covering Foundayo and the Wegovy pill.
  2. 02Dispensing trends for oral incretins shape stocking and formulary decisions for pharmacists and telehealth operators watching the shift away from injectables.
  3. 03The tracker is a periodic snapshot rather than a company disclosure; underlying script counts and sources were not detailed in the summary.

From the source

The Oral GLP-1 Tracker: Foundayo, Wegovy pill undergo minor fluctuations

Read at fiercepharma.com
PeptiPrescribed peptides from $99/moSee all →